The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak–STAT Signaling Pathway: A Case-control Study

Jafari Harandi, A., Mirzaee Sedigh, A., Ataei, M., Bayrami, S., Esmaeilzadeh, E., Sanati, M. H. (2024). 'The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak–STAT Signaling Pathway: A Case-control Study', Iranian Journal of Immunology, (), pp. -. doi: 10.22034/iji.2024.100500.2694

留言 (0)

沒有登入
gif